| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/JACS.7B02716 |
| P953 | full work available at URL | https://europepmc.org/articles/pmc5617735?pdf=render |
| P932 | PMC publication ID | 5617735 |
| P698 | PubMed publication ID | 28590725 |
| P7228 | access restriction status | open access | Q232932 |
| P50 | author | Mohammad Seyedsayamdost | Q88479944 |
| P2093 | author name string | Fei Xu | |
| Kyuho Moon | |||
| Behnam Nazari | |||
| Leah B Bushin | |||
| P2860 | cites work | Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2) | Q29547307 |
| Bioactive microbial metabolites | Q31157729 | ||
| Dereplication of peptidic natural products through database search of mass spectra | Q33614929 | ||
| A new family of bacterial regulatory proteins | Q33626593 | ||
| High-throughput platform for the discovery of elicitors of silent bacterial gene clusters | Q33665547 | ||
| How to discover new antibiotics: harvesting the parvome | Q33757045 | ||
| Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. | Q33927147 | ||
| Complete genome sequence and comparative analysis of the industrial microorganism Streptomyces avermitilis | Q33965431 | ||
| Genetic factors that influence moenomycin production in streptomycetes | Q34127518 | ||
| Natural products: a continuing source of novel drug leads | Q34328933 | ||
| Biosynthetic Gene Cluster for Surugamide A Encompasses an Unrelated Decapeptide, Surugamide F | Q87968440 | ||
| Chemical perturbation of secondary metabolism demonstrates important links to primary metabolism | Q34393211 | ||
| Natural Products as Sources of New Drugs from 1981 to 2014. | Q34512692 | ||
| Genomic basis for natural product biosynthetic diversity in the actinomycetes | Q34711979 | ||
| Extending the classification of bacterial transcription factors beyond the helix-turn-helix motif as an alternative approach to discover new cis/trans relationships. | Q35618547 | ||
| GntR Family of Bacterial Transcription Factors and Their DNA Binding Motifs: Structure, Positioning and Co-Evolution. | Q35685164 | ||
| xylE functions as an efficient reporter gene in Streptomyces spp.: use for the study of galP1, a catabolite-controlled promoter | Q36184566 | ||
| Are antibiotics naturally antibiotics? | Q36428095 | ||
| New antibiotics from bacterial natural products | Q36679241 | ||
| Antibiotics as signalling molecules | Q36732540 | ||
| Trading molecules and tracking targets in symbiotic interactions | Q37222223 | ||
| Mixed fermentation for natural product drug discovery | Q37420501 | ||
| Impact of natural products on developing new anti-cancer agents | Q37473373 | ||
| Insights into naturally minimised Streptomyces albus J1074 genome. | Q37608801 | ||
| Streptomyces and Saccharopolyspora hosts for heterologous expression of secondary metabolite gene clusters | Q37751993 | ||
| The regulation of the secondary metabolism of Streptomyces: new links and experimental advances | Q37879562 | ||
| Antibiotics as signal molecules. | Q37904976 | ||
| Streptomyces as symbionts: an emerging and widespread theme? | Q37957174 | ||
| New strategies for drug discovery: activation of silent or weakly expressed microbial gene clusters | Q38059156 | ||
| Triggers and cues that activate antibiotic production by actinomycetes | Q38125903 | ||
| Bacterial symbionts in agricultural systems provide a strategic source for antibiotic discovery | Q38127133 | ||
| Activating secondary metabolism with stress and chemicals | Q38170294 | ||
| Microbial communication leading to the activation of silent fungal secondary metabolite gene clusters. | Q38459251 | ||
| Discovery of microbial natural products by activation of silent biosynthetic gene clusters | Q38539563 | ||
| Activation and identification of five clusters for secondary metabolites in Streptomyces albus J1074. | Q38832392 | ||
| Antibiotic dialogues: induction of silent biosynthetic gene clusters by exogenous small molecules | Q38941332 | ||
| The streptomyces genome contains multiple pseudo-attB sites for the (phi)C31-encoded site-specific recombination system | Q39694905 | ||
| Strategies for the discovery of new natural products by genome mining | Q40398989 | ||
| Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugs | Q42550867 | ||
| Characterization of biosynthetic gene cluster for the production of virginiamycin M, a streptogramin type A antibiotic, in Streptomyces virginiae | Q42614130 | ||
| Mansouramycins A-D, cytotoxic isoquinolinequinones from a marine streptomycete. | Q43239734 | ||
| Effect of different classes of inhibitors on DNA gyrase from Mycobacterium smegmatis | Q43753561 | ||
| Transcriptional responses of Bacillus subtillis and thuringiensis to antibiotics and anti-tumour drugs. | Q46198377 | ||
| Complete genome sequence of the erythromycin-producing bacterium Saccharopolyspora erythraea NRRL23338. | Q48080782 | ||
| Mapping the Trimethoprim-Induced Secondary Metabolome of Burkholderia thailandensis. | Q51669780 | ||
| Novel inhibitors of prolyl 4-hydroxylase | Q67486786 | ||
| Measurement of induced beta-galactosidase activity in intact cells of Streptomyces species | Q71557713 | ||
| Green fluorescent protein as a reporter for spatial and temporal gene expression in Streptomyces coelicolor A3(2) | Q73074195 | ||
| Bacterial death by DNA gyrase poisoning | Q77148142 | ||
| Surugamides A–E, Cyclic Octapeptides with Four d-Amino Acid Residues, from a Marine Streptomyces sp.: LC–MS-Aided Inspection of Partial Hydrolysates for the Distinction of d- and l-Amino Acid Residues in the Sequence | Q78329065 | ||
| P433 | issue | 27 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Streptomyces albus | Q7623378 |
| Streptomyces | Q1144013 | ||
| Streptomyces albidoflavus | Q22286833 | ||
| H-DL-Trp-DL-Val-DL-Val-DL-xiThr-Unk-DL-Leu-DL-Val-DL-Ala-DL-Val-DL-Ala-OH | Q103816247 | ||
| cyclo[DL-Ala-DL-Val-DL-Val-DL-Lys-DL-Val-DL-Phe-DL-Leu-DL-Val] | Q103817057 | ||
| N-[4-[8-benzyl-20-butan-2-yl-17-methyl-11-(2-methylpropyl)-3,6,9,12,15,18,21,24-octaoxo-5,14,23-tri(propan-2-yl)-1,4,7,10,13,16,19,22-octazacyclotetracos-2-yl]butyl]-7-(methylamino)-5,8-dioxoisoquinoline-4-carboxamide | Q103818850 | ||
| Albuquinone A | Q104169723 | ||
| Surugamide F2 | Q104914921 | ||
| Surugamide I | Q104946655 | ||
| Albucyclone E | Q104992453 | ||
| Albucyclone F | Q105142979 | ||
| Albucyclone C | Q105176099 | ||
| Albucyclone A | Q105182180 | ||
| Albucyclone B | Q105184000 | ||
| Albucyclone D | Q105187258 | ||
| Surugamide H | Q105203612 | ||
| Surugamide G | Q105292070 | ||
| Acyl-surugamide A | Q105313259 | ||
| Surugamide F3 | Q105345377 | ||
| Surugamide J | Q105365180 | ||
| Surugamide A | Q77372486 | ||
| P6954 | online access status | open access | Q232932 |
| P304 | page(s) | 9203-9212 | |
| P577 | publication date | 2017-06-07 | |
| P1433 | published in | Journal of the American Chemical Society | Q898902 |
| P1476 | title | Discovery of a Cryptic Antifungal Compound from Streptomyces albus J1074 Using High-Throughput Elicitor Screens | |
| P478 | volume | 139 |
| Q90929349 | A genetics-free method for high-throughput discovery of cryptic microbial metabolites |
| Q57822331 | Activation of microbial secondary metabolic pathways: Avenues and challenges |
| Q91997787 | Albumycin, a new isoindolequinone from Streptomyces albus J1074 harboring the fluostatin biosynthetic gene cluster |
| Q90062296 | An Isotopic Ratio Outlier Analysis Approach for Global Metabolomics of Biosynthetically Talented Actinomycetes |
| Q92108268 | Bioactivity-HiTES Unveils Cryptic Antibiotics Encoded in Actinomycete Bacteria |
| Q52368924 | Butenolides from Streptomyces albus J1074 Act as External Signals To Stimulate Avermectin Production in Streptomyces avermitilis. |
| Q92186698 | Cebulantin, a Cryptic Lanthipeptide Antibiotic Uncovered Using Bioactivity-Coupled HiTES |
| Q89065631 | Chemical Elicitors of Antibiotic Biosynthesis in Actinomycetes |
| Q98457972 | Discovery of a Cryptic Depsipeptide from Streptomyces ghanaensis via MALDI-MS-Guided High-Throughput Elicitor Screening |
| Q52693058 | Diverse and Abundant Secondary Metabolism Biosynthetic Gene Clusters in the Genomes of Marine Sponge Derived Streptomyces spp. Isolates. |
| Q90334007 | Genome Mining Coupled with OSMAC-Based Cultivation Reveal Differential Production of Surugamide A by the Marine Sponge Isolate Streptomyces sp. SM17 When Compared to Its Terrestrial Relative S. albidoflavus J1074 |
| Q62673366 | Heterologous expression-facilitated natural products’ discovery in actinomycetes |
| Q64166981 | Mining for Microbial Gems: Integrating Proteomics in the Postgenomic Natural Product Discovery Pipeline |
| Q89881628 | Multi-Omic Analyses Provide Links between Low-Dose Antibiotic Treatment and Induction of Secondary Metabolism in Burkholderia thailandensis |
| Q90192470 | Natural Products as a Foundation for Drug Discovery |
| Q48149208 | Novel Bioactive Paulomycin Derivatives Produced by Streptomyces albus J1074. |
| Q89043822 | Recent advances in activating silent biosynthetic gene clusters in bacteria |
| Q92538313 | Regulation of Antibiotic Production by Signaling Molecules in Streptomyces |
| Q57093308 | Response of Hypogean Actinobacterial Genera Secondary Metabolism to Chemical and Biological Stimuli |
| Q92761494 | Secondary nucleotide messenger c-di-GMP exerts a global control on natural product biosynthesis in streptomycetes |
| Q57479721 | Streptomycetes: Surrogate hosts for the genetic manipulation of biosynthetic gene clusters and production of natural products |
| Q41670091 | Though Much Is Taken, Much Abides: Finding New Antibiotics Using Old Ones |
Search more.